SCHEMBL3377441

SCHEMBL3377441

CCOC(=O)c1cc(-c2cccc(Cl)c2)c2ncc(C)n2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
MAPT P10636 3/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C19 P33261 3/20 0.44
CYP2C9 P11712 2/20 0.44
JMJD6 Q6NYC1 2/20 0.43
GRM5 P41594 1/20 0.43
JAK2 O60674 1/20 0.42
JAK3 P52333 1/20 0.42
HTT P42858 1/20 0.42
GPR119 Q8TDV5 1/20 0.42
DYRK3 O43781 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377260 0.89 MAPK14 (0.43) NPC1RAB9ASMN1; SMN2MAPTJAK2
SCHEMBL3378785 0.83 GABRA2 (0.47) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL3377892 0.80 GRM5 (0.57) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL3565469 0.79 HPGD (0.62) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL3381843 0.78 GPR119 (0.39) RAB9ASMN1; SMN2MAPTJAK2GPR119
SCHEMBL5988159 0.73 TRPM8 (0.46) GAAGABRA2GABRB2MAPTTRPM8
SCHEMBL3561448 0.72 RAB9A (0.65) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5988350 0.72 TRPM8 (0.46) ALDH1A1GABRA2GABRB2MAPTTRPM8
SCHEMBL12991545 0.72 TRPV1 (0.53) NPC1RAB9ASMN1; SMN2GABRA2GABRB2
SCHEMBL3381952 0.72 MAPK14 (0.43) KDM4EGABRA2GABRB2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010059838-A2 PDE4 INHIBITORS SELECTIVE FOR THE LONG FORM OF PDE4 FOR TREATING INFLAMMATION AND AVOIDING SIDE EFFECTS DECODE GENETICS EHF (IS) 2010-05-27 WO disclosed
WO-2010059836-A1 SUBSTITUTED AZA-BRIDGED BICYCLICS FOR CARDIOVASCULAR AND CNS DISEASE DECODE GENETICS EHF (IS) 2010-05-27 WO disclosed